Unaudited financial results for the quarter ended june 30, 2006
PARTICULARS
3
months ended 30.06.06 Unaudited
3
months ended 30.06.05 Unaudited
Year
ended 31.03.06 Audited
Net Sales/Operational Income
5296.88
7997.44
32341.62
Others Income
270.46
18.77
103.41
TOTAL EXPENDITURE :
4280.79
6521.40
26300.61
(a) (Increase)/decrease in stock in trade
(411.44)
(89.14)
(1595.27)
(b) Consumption of Raw Material
3021.46
5379.97
22070.92
(c) Staff Cost
192.82
134.96
640.02
(d) Other expenditure
1477.94
1095.61
5184.93
Interest
487.72
235.34
1245.20
Depreciation
289.76
146.83
810.88
Profit(+)/Loss(-) before tax
509.05
1112.64
4088.34
Provision for taxation
62.12
93.54
361.14
Provision for fringe benefit tax
1.38
1.00
6.38
Net Profit/Loss before Deferred Tax
445.56
1018.09
3720.82
Provision for deferred tax
22.16
13.67
242.14
Net Profit/Loss
423.40
1004.43
3478.68
Paid up Equity Share Capital
2152.00
Reserve excluding revaluation reserves
16810.23
EPS (Rs.) Basic
1.95
5.46
17.52
Diluted
1.95
5.33
17.00
Aggregated on Non-Promoters Shareholding
No. of Shares
15504594
% of Shareholding
72.05%
Notes:
a) The Company had issued 6,00,000 equity shares to the Promoters group companies and FIIs during the quarter upon the conversion of equal number of warrants at a price of Rs. 115/- per warrant and raised a sum of Rs. 621Lacs. The utilization of funds upto 30th June, 2006 is as under :
a)
R & D Mohali Project Funding including capital advances
75
b)
Derabassi facility expansion including capital advances
346
c)
Funds used for working capital and margin money
200
b) Summary of Investor complaints. Opening :Nil, Received during the quarter:5, Resolved :5, Closing :Nil.
c) The previous year figures have been regrouped and rearranged wherever necessary.
d) The Company is exclusively in the pharmaceutical business segment.
e) The above financial results were taken on record by the Board of Directors at its meeting held on 29th July, 2006.
For Ind-Swift Laboratories Limited
Sd/-
Sd/-
Place:Chandigarh
(N.R.MUNJAL)
(V.K.MEHTA)
Date: 29th July, 2006
Managing Director
Jt.Managing Director
To know about our Formulation Division, please visit us at Ind-Swift Limited, our other group company.
